Skip to main content
Single-Credit On Demand

Emerging Evidence for Marijuana-Induced Psychosis


Total Credits: 1 including 1 AMA PRA Category 1 Credit(s)™, 1 AOA Category 1-A Credit(s)

Average Rating:
   6
Topics:
Adolescent |  AMA PRA Category 1 Credit |  AOA Category 1-A Credit |  Cannabis |  Family Medicine |  Physical Therapy |  Primary Care |  Psychology |  Substance Abuse
Faculty:
Marcus Iszard, PhD, P.I.
Duration:
57 Minutes
Expiration:
Access till 07/27/2026 after purchase.


Description

This program will expire and must be completed by 07/27/26.

** Please note this program was a part of the VOC 2023. You will not want to choose this program if you completed this individual program as part of the VOC 2023. **

During this presentation, Dr. Iszard will address the current use and abuse of substances that lead to behavioral and psychological adverse effects. He will identify associated psychological effects that result from the legal and illegal use of over-the-counter and prescribed substances. The presenter will also dispel the myth that THC and other psychoactive substances do not cause permanent psychiatric injury to the user. 

Learning Objectives:
1)  Learners will develop a pharmacologic rationale and understanding of the effects that THC and other psychoactive substances have on behavior, brain, and personality development in adolescents and adults.
2)  Learners will apply the information from this presentation to educate their patients on the potential adverse and undesired effects of using legally obtained THC psychoactive substances.
3)  Learners will provide validated and informed counseling to their patients and/or family members, empowering them to make reasonable and informed decisions regarding the use of these increasingly accessible and affordable substances.
4)  Learners will be able to confidently engage their patients in informed discussions of the risks and benefits of using psychoactive substances like THC to address physical and psychological issues.

Accreditation Statement:
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.  MAOPS designates this program for a maximum of 1 AOA Category 1-A CME Credit(s) and will report CME and specialty credits commensurate with the extent of the physician’s participation.

The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)ä.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Disclosure:
None of the planners for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Grievance Policy for AOA Credit:
All grievances should be in writing and should specify the nature of the grievance.  Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee.  All grievances will receive an initial response in writing within 30 days of receipt.  If the participant does not receive a satisfactory response, they can submit a complaint in writing to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.

Handouts

Faculty

Marcus Iszard, PhD, P.I.'s Profile

Marcus Iszard, PhD, P.I. Related Seminars and Products


Dr. Marcus Iszard is an Associate Professor of Pharmacology at Kansas City University, College of Osteopathic Medicine in Kansas City and Joplin, Missouri. He is also a Consultant and a Licensed Private Drug Investigator. He provides consulting and investigation services for law enforcement agencies and private/corporate law firms for criminal or civil legal matters. Dr. Iszard received his Doctor of Philosophy (Pharmacology/Toxicology) from Florida A&M University in Tallahassee, Florida. He completed his fellowship at the University of Kansas School of Medicine, Department of Pharmacology, Toxicology, and Therapeutics in Kansas City, Kansas.

Dr. Iszard is primarily trained as a pharmacologist and toxicologist. Dr. Iszard has professional experience in drugs, poisons, and medication investigations and forensic consultation. He has over 25 years of comprehensive teaching experience as a veteran professor in pharmacology, toxicology, and therapeutics for clinical, research, and investigation courses for pharmacy, medical, dental, and nursing students. He has over 20 years of investigative and forensic pharmacology/toxicology experience and teaching. He has testimony and legal deposition experience as a certified toxicology expert with state and federal court systems.

Dr. Iszard was awarded the Lawrence Ferring Faculty Award as Teacher of the Year in 2004 at Xavier University of Louisiana, College of Pharmacy, New Orleans, Louisiana. He is also a member of the Rho Chi Pharmacy National Honor Society.

Dr. Iszard is married and has two children. He enjoys ham radio in his spare time.

Dr. Iszard discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients relative to the content of this presentation.

 


Reviews

5
4
3
2
1

Overall:      4.2

Total Reviews: 6